ACTICOAT^◊ FLEX Antimicrobial Barrier Dressings

Combines nanocrystalline silver (NCS) technology with a flexible low-adherent layer to conform to body contours, delivering a sustained antimicrobial action for up to 7 days^*1-5

Act with certainty

A large surface area of NCS structure enables sustained release of silver into the wound fluid, while the dressing helps to promote and retain a moist environment, when used with an appropriate secondary dressing. Shown to deliver sufficient silver at a consistent concentration to remain bactericidal.^**2-10

Product feature

Application

Evidence and Case Studies

Medical Education

No results

Disclaimer

^*Depending on dressing selection. ACTICOAT FLEX 3 offers up to 3 days’ use. ACTICOAT FLEX 7 offers up to 7 days’ use.

^**As demonstrated in vitro.

Recall and Complaints

Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.

Terms & Conditions and Warranties

Citations

1. Smith+Nephew 2011. Internal report. SR/CE/036/ACB.

2. Smith+Nephew 2008. Internal report. DOF 0810016.

3. Smith+Nephew 2008. Internal report. DOF 0810017.

4. Smith+Nephew 2008. Internal report. DOF 0810012.

5. Smith+Nephew 2008. Internal report. DOF 0810013.

6. Smith+Nephew. A 17-Day wound healing study in full-thickness wounds in minipigs. Internal Statement.

7. Wright JB, et al. Am J Infect Control. 1998;26(6):572 - 577.

8. Wright JB, et al. Am J Infect Control. 1999;27(4):344 - 350.

9. Smith+Nephew 2017. Internal report. DS/16/363/R2.

10. Westaim Biomedical 2001. Internal report - 971030.

11. Smith+Nephew 2008. Internal report. DS/08/123/R1.

12. Cuttle L, et al. Burns. 2007;33(6):701 - 707.

13. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.001.v2.

14. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.002.v2.

15. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.003.v2.

16. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.004.v2.

17. Gago M, et al. Wounds. 2008;20(10):273 - 278.

18. Demling RH, et al. Burns. 2002;28(3):264 - 266

19. Smith+Nephew 2008. Internal report. DOF 0810018.

20. Smith+Nephew 2008. Internal report. DOF 0810014.

21. Yin HQ, et al. J Burn Care Rehabil. 1999;20(3):195 - 200.

22. Wright JB, et al. Wounds. 1998;10(6):179 - 188.

23. Smith+Nephew 2008. Internal report. DS/08/062/R1.

24. Westaim Biomedical 2000. Internal report - 001213.

25. Westaim Biomedical 2001. Internal report - 010322.

26. Glik J, et al. Int Wound J. 2018;15(3):344 - 349.